$3.26
-0.12 (-3.55%)
Open$3.37
Previous Close$3.38
Day High$3.38
Day Low$3.21
52W High$9.33
52W Low$4.50
Volume—
Avg Volume288.0K
Market Cap282.98M
P/E Ratio—
EPS$-1.58
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+520.2% upside
Current
$3.26
$3.26
Target
$20.22
$20.22
$15.45
$20.22 avg
$24.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 497.57M | 429.87M | 70.84M |
| Net Income | 3.29M | 2.56M | 13.06M |
| Profit Margin | 0.7% | 0.6% | 18.4% |
| EBITDA | 21.23M | 17.42M | 20.07M |
| Free Cash Flow | — | — | 11.95M |
| Rev Growth | +15.8% | +15.8% | +2.1% |
| Debt/Equity | 0.18 | 0.18 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |